Oracle filed on 2 November to sell $10 billion of common stock and, in a separate offering running at the same time, $10 billion of senior notes in six series, according to two preliminary prospectus supplements it filed with the SEC. Together the two offerings come to $20 billion, the same amount Oracle set as its limit on new capital-markets funding through fiscal 2030 at its Investor Day on 28 October, five days earlier.
By our arithmetic from the filings, the $10 billion of stock is about 76.5 million shares at the $130.67 last reported sale price on 30 October that the stock filing cites, or about 2.5% of the 3,023,726,695 shares outstanding on 31 August. The $10 billion of notes would lift Oracle’s total debt of $125.3 billion at 31 August by about 8.0%, before fees. Neither offering had been priced when the filings were made.
The key insight: Oracle filed on 2 November to sell $10 billion of common stock and $10 billion of notes in concurrent offerings, according to its SEC filings, matching the $20 billion limit on new capital raises it set five days earlier; by our arithmetic the stock is about 2.5% of its shares at the 30 October price and the notes add about 8.0% to its debt, before fees.
Oracle filed a new automatic shelf registration, Form S-3ASR, at 12:30 UTC on 2 November. The notes supplement followed at 13:12 UTC and the stock supplement at 13:16 UTC, according to the SEC’s filing index. The notes supplement lists floating rate notes due 2029 and fixed rate notes due 2029, 2031, 2033, 2037 and 2046, with the amount of each series and the interest rates left blank.
Each supplement says the other offering is not a condition of its closing. Both say the net proceeds of the two offerings “will be used for general corporate purposes, which may include capital expenditures, repayment of indebtedness, future investments or acquisitions and payment of cash dividends on or repurchases of our common stock.”
Both supplements name BofA Securities as global coordinator, with Wells Fargo Securities, Citigroup, BNP Paribas, Deutsche Bank Securities, J.P. Morgan, Goldman Sachs, HSBC and others among the joint book-running managers. In the stock filing, Oracle agrees not to sell further common stock for 60 days without the consent of the representative, subject to exceptions.
Business Pill · Financial Conditions Explained
Financial conditions explained: how the cost and availability of credit move across markets. It teaches the general idea only and says nothing about any company in this story.
What Was Posted on X
$ORCL is preparing a $10B bond sale across six tranches just days after telling investors it would limit additional debt to that same amount through FY2030 effectively front-loading its entire borrowing plan.
With the capacity already contracted to customers like $META, $NVDA and OpenAI Iโm super curious to see what credit markets will charge Oracle to finance the buildout as capex peaks.
@StockSavvyShay wrote that Oracle is preparing a $10 billion bond sale in six tranches days after telling investors it would limit additional debt to that amount through fiscal 2030, which the poster called front-loading its entire borrowing plan. The poster also says the capacity is already contracted to customers including Meta, Nvidia and OpenAI, and asks what credit markets will charge Oracle; those customer names are the poster’s.
Oracle total debt and stockholders’ equity at 31 August 2026, and the same balances with each $10 billion offering added, before fees. Source: Oracle preliminary prospectus supplements (424B2, 424B5) filed with the SEC on 2 November 2026; capitalization as of 31 August 2026. The after-offering figures are our arithmetic; the offerings were not yet priced.
Against the $20B Cap
Oracle’s 28 October Investor Day release said it was “committed to limiting additional funding to be raised in the capital markets for its FY27-FY30 investment cycle to $20 billion”, “currently expected to be $10 billion in equity and $10 billion in gross debt”. The release said that limit excludes refinancing of existing debt and comes “in addition to the $20 billion at-the-market equity raise completed in the first quarter of fiscal 2027”.
The two offerings filed on 2 November match that split: $10 billion of common stock and $10 billion of notes. By our arithmetic, adding $10 billion to the $66.8 billion of Oracle stockholders’ equity at 31 August would lift it by about 15.0%, and adding $10 billion to total debt would take it to $135.3 billion, both before underwriting discounts and expenses.
Fitch Ratings’ Oracle page lists its BBB long-term and F2 short-term issuer default ratings as affirmed on 2 November. Headlines carried on X by @zerohedge said Fitch put Oracle’s capital raise at $20 billion including $10 billion of equity. A Bloomberg headline relayed on X the same morning said Oracle shares extended their drop to 3.5% after the stock offering was filed.
Connecting the Coverage
On 28 October we reported Oracle’s Investor Day targets, including the $20 billion limit on new capital raises. On 31 October we put that limit at about 70% of the $28.499 billion Oracle spent on property and equipment in the quarter to 31 August. What is new on 2 November is the timing: both halves of the limit were filed for on the same morning.
The share price had already moved before the filings. Oracle closed at $144.54 on 28 October, according to the Yahoo Finance quote data in our earlier report, and the stock filing gives $130.67 as the last reported sale price on 30 October, about 9.6% lower by our arithmetic. Oracle’s offerings come on the same day as Alphabet’s second euro bond sale of 2026, which had not been priced either.
The Structural Read
As we read the filings, the order matters less than the timing: the shelf, the notes supplement and the stock supplement were all filed within about 46 minutes on the same morning, by the SEC’s filing index.
As we read the comparison with 28 October, the limit Oracle described as a ceiling through fiscal 2030 is the amount it has now filed to raise in one day, if both offerings are completed.
Oracle, 28 October 2026 Investor Day release, as quoted in our earlier report
“committed to limiting additional funding to be raised in the capital markets for its FY27-FY30 investment cycle to $20 billion”
Three Implications
FOR SHAREHOLDERS At the 30 October price of $130.67 cited in the stock filing, $10 billion buys about 76.5 million shares, about 2.5% of the 3,023,726,695 shares outstanding on 31 August, by our arithmetic.
FOR CREDITORS The notes filing’s capitalization table shows total debt of $125.3 billion at 31 August; $10 billion more would take it to $135.3 billion, by our arithmetic, before fees.
FOR THE CAP Oracle’s release said the $20 billion limit excludes refinancing of existing debt and comes in addition to a $20 billion at-the-market equity raise completed in the first quarter of fiscal 2027.
The framework argues: “It is a sovereign-scale financing problem dressed in tech-company clothing”.
As we read it, Oracle’s two filings are that financing question in a single company: stock and debt sold side by side to fund the build. The framework is the owner’s argument and does not discuss Oracle’s 2 November offerings.
Neither offering was priced when the filings were made, so the number of shares, the share price, the size of each note series and the interest rates are not yet known. The 76.5 million share count uses the 30 October price, not the offering price. Oracle has not said how it will split the proceeds among the uses its filings list. We did not contact Oracle or Fitch, and we could not read Fitch’s commentary beyond its ratings page.
This Week In The AI Supercycle
Anthropic’s Reality Check, The Capital Squeeze, & The New World Order
This week’s issue: for two years the AI build-out was priced as a growthstory. This week it started being priced as a credit story.
Five days after setting a $20 billion limit on new capital raises through fiscal 2030, Oracle filed to raise that full amount in two concurrent offerings, $10 billion of stock and $10 billion of notes, according to its SEC filings. By our arithmetic, the stock is about 2.5% of its shares at the 30 October price and the notes add about 8.0% to its debt, before fees.
A note on sourcing. Offering terms are from Oracle’s preliminary prospectus supplements (Forms 424B2 and 424B5) and its Form S-3ASR, filed with the SEC on 2 November 2026; filing times are from the SEC’s filing index. The offerings were not priced when we read them. Share counts, percentages and sums are our arithmetic and are gross of underwriting discounts and expenses. Fitch’s affirmations are from its ratings page; the Fitch $20 billion line and the share-price moves are headlines carried on X. We did not contact Oracle or Fitch.
Gennaro Cuofano is a CRO and tech executive who has worked in AI since late 2015, starting with bringing NLP, natural-language generation, voice and chatbot products to the marketing industry. His background is in law and finance: he holds a Master's degree in Law and an International MBA with an emphasis on corporate finance (LUISS Business School and the University of San Diego, 2012), and worked as a financial analyst at a real-estate investment firm in San Diego and as an assistant controller. His work focuses on business model strategy, business engineering and, more broadly, structural analysis: how companies make money, read from their own filings. He created FourWeekMBA and leads research there and at The Business Engineer, his newsletter on AI and business strategy, with over 95,000 subscribers and more than 1,000 published analyses. His writing has also appeared on Entrepreneur (for example, How to Digitize a Family Business in Europe) and HackerNoon. Find him on LinkedIn and Substack. See how we source.
